Jane Street’s Eterna Therapeutics ERNA Stock Holding History

Jane Street’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.19K	Buy	+1,647	New	+$26.3K	﹤0.01%	11320
2022 Q3	–	Sell	-3	Closed	-$10K	–	9870
2022 Q2	$10K	Buy	3 +1	+50%	+$7.18K	﹤0.01%	9309
2022 Q1	$27K	Sell	2 -3	-60%	-$56.9K	﹤0.01%	9860
2021 Q4	$145K	Buy	5 +3	+150%	+$163K	﹤0.01%	9023
2021 Q3	$148K	Buy	+2	New	+$173K	﹤0.01%	9069
2020 Q3	–	Sell	-1	Closed	-$48K	–	7313
2020 Q2	$48K	Buy	+1	New	+$21.7K	﹤0.01%	6873

Other funds holding ERNA

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's ERNA Position: Q1 2026 in Review

Jane Street opened a new position in Eterna Therapeutics (ERNA) in Q1 2026: 1,647 shares worth $8.19K. The stake represents ﹤0.01% of the portfolio and ranks #11320 among its holdings. This is a return to the name: Jane Street previously reported a position in ERNA as recently as Q2 2022.

Jane Street first reported a position in ERNA in Q2 2020 and has held it in 6 quarters since. The position peaked at $148K in Q3 2021. 15 funds tracked by Wall St. Rank hold ERNA as of Q1 2026.

Jane Street held 1,647 shares of Eterna Therapeutics worth $8.19K as of Q1 2026.
Eterna Therapeutics was a new Jane Street position in Q1 2026.
Eterna Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11320 holding.
Jane Street first reported a position in Eterna Therapeutics in Q2 2020 and has held it in 6 quarters since.
Jane Street's Eterna Therapeutics position peaked at $148K in Q3 2021.
15 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.